Acid-related disorders and use of antisecretory medication

被引:0
|
作者
Lassen, Annemarie Touborg [1 ]
机构
[1] Odense Univ Hosp, Dept Med Gastroenterol, DK-5000 Odense C, Denmark
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:18 / 30
页数:13
相关论文
共 50 条
  • [31] Costs of acid-related disorders to a health maintenance organization
    Levin, TR
    Schmittdiel, JA
    Kunz, K
    Henning, JM
    Henke, CJ
    Colby, CJ
    Selby, JV
    AMERICAN JOURNAL OF MEDICINE, 1997, 103 (06): : 520 - 528
  • [32] Optimizing the pharmacology of acid control in acid-related disorders - Panel discussion
    Maton, PN
    Howden, CW
    Freston, JW
    Tolman, KG
    Hunt, RH
    Hirschowitz, BI
    Sontag, SJ
    Orlando, RC
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1997, 92 (04): : S20 - S21
  • [34] Rabeprazole: A proton pump inhibitor for the treatment of acid-related disorders
    Feret, B
    Quercia, RA
    Cappa, J
    FORMULARY, 1999, 34 (04) : 313 - +
  • [36] An update of pharmacology, efficacy, and safety of vonoprazan in acid-related disorders
    Savarino, Vincenzo
    Antonioli, Luca
    Fornai, Matteo
    Marabotto, Elisa
    Demarzo, Maria Giulia
    Zingone, Fabiana
    Ghisa, Matteo
    Barberio, Brigida
    Zentilin, Patrizia
    Ribolsi, Mentore
    Savarino, Edoardo
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 16 (05) : 401 - 410
  • [37] Lansoprazole An update of its place in the management of acid-related disorders
    Matheson, AJ
    Jarvis, B
    DRUGS, 2001, 61 (12) : 1801 - 1833
  • [38] REVIEW: Efficacy of Rabeprazole Once Daily for Acid-Related Disorders
    Frank Lanza
    Karna Dev Bardhan
    Carlos Perdomo
    Robert Niecestro
    Jay Barth
    Digestive Diseases and Sciences, 2001, 46 : 587 - 596
  • [39] Lansoprazole oro-dispersible tablet - Pharmacokinetics and therapeutic use in acid-related disorders.
    Baldi, F
    DRUGS, 2005, 65 (10) : 1419 - 1426
  • [40] TransAtiantic-Pacific Summit: dialogues in acid-related disorders
    Peura, DA
    Malfertheiner, P
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 21 : 1 - +